Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048). (Q46866366)
Jump to navigation
Jump to search
scientific article published in April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048). |
scientific article published in April 2008 |
Statements
1 reference
Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048). (English)
1 reference
Amin A Nomeir
1 reference
Birendra N Pramanik
1 reference
Larry Heimark
1 reference
Frank Bennett
1 reference
John Veals
1 reference
Peter Bartner
1 reference
Maryjane Hilbert
1 reference
Anil Saksena
1 reference
Paul McNamara
1 reference
Viyyoor Girijavallabhan
1 reference
Ashit K Ganguly
1 reference
Raymond Lovey
1 reference
Russell Pike
1 reference
Haiyan Wang
1 reference
Yi-Tsung Liu
1 reference
Pramila Kumari
1 reference
Walter Korfmacher
1 reference
Chin-Chung Lin
1 reference
Anthony Cacciapuoti
1 reference
David Loebenberg
1 reference
Roberta Hare
1 reference
George Miller
1 reference
Cecil Pickett
1 reference
1 April 2008
1 reference
1 reference
43
1 reference
509-517
1 reference
4
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference